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INTRODUCTION
Amoebic gill disease (AGD), caused by the para-
sitic amoeba Neoparamoeba perurans, is considered
to constitute one of the major health challenges in
marine cultured Atlantic salmon Salmo salar (Young
et al. 2007, Adams et al. 2012) and was first described
affecting farmed salmonids in Tasmania, Australia,
and Washington state, USA, in the mid-1980s (Kent
et al. 1988). Over the last decade, the disease has
become more widespread and has now been re -
ported in the majority of Atlantic salmon-producing
countries, including Norway (Steinum et al. 2008),
Chile (Bustos et al. 2011) and Scotland (Rodger 2014).
In addition to salmonids, AGD has been reported in
other fish species, such as turbot Scophthalmus max-
imus (Dyková et al. 1998, Mouton et al. 2014), sea
bass Dicentrarchus labrax, sharp-snout sea bream
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ABSTRACT: Amoebic gill disease (AGD) is a proliferative gill disease of marine cultured Atlantic
salmon Salmo salar, with the free-living protozoan Neoparamoeba perurans being the primary
aetiological agent. The increased incidence of AGD in recent years presents a significant chal-
lenge to the Atlantic salmon farming industry in Europe. In this study, a real-time TaqMan® PCR
assay was developed and validated to detect Neoparamoeba perurans on Atlantic salmon gills and
further used to monitor disease progression on a marine Atlantic salmon farm in Ireland in con-
junction with gross gill pathology and histopathology. The assay proved specific for N. perurans,
with no cross-reactivity with the related species N. pemaquidensis, N. branchiphila or N. aestua-
rina, and was capable of detecting 2.68 copies of N. perurans DNA µl−1. Although the parasite was
detected throughout the 18 mo period of this study, mortality peaks associated with clinical AGD
were only recorded during the first 12 mo of the marine phase of the production cycle. The initial
AGD outbreak resulted in peak mortality in Week 17, which was preceded by PCR detections
from Week 13 onwards. Freshwater treatments were an effective method for controlling the dis-
ease, resulting in a reduction in the weekly mortality levels and also a reduction in the number of
PCR-positive fish. In comparison to traditional diagnostic methods, our PCR assay proved to be
highly sensitive and a valuable tool to monitor disease progression and, therefore, has the poten-
tial to provide information on the timing and effectiveness of treatments.
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Diplodus puntazzo, ayu Plecoglossus altivelis (Nowak
et al. 2014), and ballan wrasse Labrus bergylta (Karls -
bakk et al. 2013).
In Ireland, AGD was first recorded in 1995 in a
number of marine Atlantic salmon sites (Rodger &
McArdle 1996, Palmer et al. 1997) and continued to
occur sporadically in a small number of sites since the
first outbreaks (Bermingham & Mulcahy 2007). Initial
outbreaks of the disease in Ireland were confined to
warm dry summers, although in recent years more
widespread and sustained infections have become
more common (Rodger & McArdle 1996, Rodger
2014). If left untreated, AGD can cause significant
mortality of up to 10% per week; however, fresh-
water baths of 2 to 4 h have proven to be an effective
treatment strategy (Munday et al. 2001, Parsons et al.
2001). An 86% reduction in the number of amoeba
remaining in the gills has been observed following
freshwater baths (Clark et al. 2003). However, this
method of treatment can add extra costs and is labour-
intensive, and several treatments may be required
over the course of a production cycle (Nowak 2012).
Currently, the most financially viable and non-
destructive means for the assessment of AGD on a
commercial scale is through the gross pathological
assessment of the gill arches to identify multifocal
lesions characterised by white mucoid patches (Clark
& Nowak 1999, Adams et al. 2004) for which a gill
scoring method has been developed (Taylor et al.
2009). However, this approach is a presumptive
means by which to confirm the presence of AGD and
is open to misinterpretation because the reactions of
gills are limited and AGD lesions are difficult to
 distinguish from lesions caused by other pathogens
or irritants. The technique and experience of the
observer can also influence the outcome of the
assessment (Adams et al. 2004). Therefore, the use of
gill scores in the detection of lesions and patches only
indicates an altered gill condition and does not
specifically identify the aetiology (Adams et al. 2004).
Lesions and patches do not always coincide with
AGD in salmon and are less reliable in the early
stages of an infection or less severe cases (Clark &
Nowak 1999). While clinical screening is accepted at
the farm level as a monitoring tool, further investiga-
tion through histological and molecular means is
required for accurate identification of the causal
agent, particularly in new locations or to identify dif-
ferent species of the genus Neoparamoeba (Nowak
et al. 2002). Histological diagnosis of AGD is con-
firmed through observation of gill hyperplasia,
lamellar fusion, vesicle formation and the presence
of amoebae with an associated parasome (Clark &
Nowak 1999, Rodger 2014). Histology is limited in its
ability to specifically identify Neoparamoeba spp. as
they are morphologically indistinguishable (Dyková
et al. 2000). Both gross and histological examinations
have been reported to underestimate the prevalence
of AGD, particularly in the lower prevalence range
(Clark & Nowak 1999).
In recent years, real-time PCR assays have become
a more widely used diagnostic tool for the detection
and identification of aquatic pathogens due to their
robustness, sensitivity, high throughput and quick
turnaround (Monis & Giglio 2006, Purcell et al. 2011).
Since N. perurans was first described as the cau -
sative agent of AGD (Young et al. 2007) in marine-
farmed Atlantic salmon, there have been 2 real-time
PCR methods published, based on both SYBR Green
(Bridle et al. 2010) and TaqMan chemistries (Frin -
guelli et al. 2012). TaqMan® chemistry is generally
thought to offer several advantages over SYBR®
Green (Martenot et al. 2010, Fringuelli et al. 2012). In
particular, the incorporation of minor-groove-binders
(MGB) allows for the raising of melting temperatures
of the probes (enabling the use of shorter probes) and
the integration of the internal hydrolysis probe pro-
vides greater specificity in comparison to the inter -
calating dye assays due to the incorporation of any
amplification products in the dye (Gunson et al. 2006,
Purcell et al. 2011). The ability of the assay devel-
oped by Fringuelli et al. (2012) to detect N. perurans
in field samples was not established, and although
the assay performed well, issues occurred with false
negative results (defined as a negative PCR result
from a fish sample with clinical AGD) in a number of
field samples tested by our laboratory (authors’
unpubl. data). It was therefore decided to develop an
alternative assay based on TaqMan chemistry.
Molecular diagnostics have the potential to fulfil a
role as an early warning and monitoring tool that
would greatly compliment traditional diagnostic
methods, particularly in the early stages of infection
when clinical signs may be absent. The aim of this
study was to develop an alternative TaqMan® assay
for the detection of N. perurans according to MIQE
guidelines (Bustin et al. 2009) and investigate its
application in monitoring the disease through a lon-
gitudinal study on a marine Atlantic salmon site dur-
ing a single production cycle. Results obtained from
the molecular assay were also compared to gill scores
and histopathology results, to determine if the assay
could potentially provide a more rapid, sensitive and
highly specific diagnostic tool in order to provide
timely information on the initial infection and the
potential timing of treatments.
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MATERIALS AND METHODS
Amoeba isolates and culture
Neoparamoeba perurans was isolated from AGD-
affected farmed Atlantic salmon in the west of Ireland
using a method adapted from Morrison et al. (2004).
Gill samples from infected salmon were excised and
placed into 25 cm2 tissue culture flasks (Costar) filled
with sterile seawater and transported, at ambient
temperature, overnight to the laboratory. On arrival,
the culture flasks were screened for the presence of
amoeba adhered to the flask surface. Once observed,
the seawater was removed, and the flask was rinsed
3 times with sterile seawater. Then, 0.5 ml trypsin-
EDTA 0.05% (Gibco®) was added to the flask and
monitored for 3 to 5 min until the majority of amoebae
were free-floating. A further 3 seawater washes were
completed, and the seawater was transferred to a
50 ml falcon tube which was then centrifuged at
800 × g for 10 min. The supernatant was discarded,
and the pellet was re-suspended in 10 ml sterile sea-
water (salinity 35) and poured onto a 0.1% malt yeast
agar (MYA) plate. Amoebae cultures were maintained
as described by Crosbie et al. (2012). Neoparamoeba
pemaquidensis (ATCC®50172™) was obtained from
the American Type Culture Collection (ATCC) and
cultured according to the protocol provided. Addi-
tional ethanol-fixed samples of N. pemaquidensis
(strain GILL NOR1/I), N. branchiphila (strain RP) and
N. aestuarina (strain SU03) were kindly provided by
the Insti tute of Parasitology, Academy of Sciences,
Czech Republic.
DNA extraction and conventional PCR of 
cultured  amoebae
All DNA extractions (cultured amoebae, ethanol-
fixed amoebae and gill samples) were performed us-
ing a QIAamp DNA Mini kit (Qiagen) according to
the manufacturer’s instructions for animal tissue, and
the eluted DNA was stored at −20°C. To confirm the
presence of N. perurans in the culture, amoebae were
physically detached from the agar using a spreading
bar and 10 ml of the amoeba-seawater solution
overlay transferred to a 15 ml universal tube, which
was immediately centrifuged at 800 g for 10 min. The
supernatant was discarded, and the amoeba pellet
was lysed in 180 µl of ATL buffer and 20 µl of pro-
teinase K. Extracted DNA was tested by conventional
PCR as described by Young et al. (2008). Additional
DNA extractions were performed on N. pemaquiden-
sis, N. branchiphila and N. aestuarina, and universal
eukaryotic primers (ERIB1 and ERIB10) selected from
Barta et al. (1997) targeting the 18S ribosomal DNA
gene were used for PCR amplification. All PCR prod-
ucts were run on a 1.5% (w/v) agarose gel in TAE
buffer (40 mM Tris, 20 mM acetic acid, 2 mM EDTA),
stained with ethidium bromide and visualized with
the Quantity One, 1-D Analysis System software on
a UV Transluminator (Bio-Rad). PCR products con-
firmed as N. perurans were subsequently purified and
sequenced commercially (Sequiserve, Germany).
Real-time primer and probe design
The PCR primer pair and TaqMan MGB probe were
selected from alignments of previously published se-
quence data of the 18S rRNA gene sequences of N.
perurans (EF216903-EF216905). Based on this align-
ment, a forward primer ‘NP1’ (5’-AAAAGACCATGC-
GATTCGTAAAGT-3’), a reverse primer ‘NP2’ (5’-C -
AT TCTTTTCGGAGAGTGGAAA TT-3’) and a probe
‘NPP’ (6-FAM- ATCATGATT C ACCATATGTT-MGB)
were designed using Primer Express (Life Techno -
logies). The primers generated an amplicon of 70 bp
and were obtained from Sigma; the probe was from
Life Technologies.
TaqMan real-time PCR
Following assay pre-optimisation experiments (data
not shown) using the Applied Biosystems standard
protocols (http://doc.appliedbiosystems.com), each
real-time PCR reaction mixture contained 5 µl tem-
plate, 12.5 µl TaqMan® Universal 2  Master Mix (Ap-
plied Biosystems), 300 nM NP1, 900 nM NP2, 200 nM
NPP and made up to 25 µl with MBG H2O. The ther-
mal profile of the real-time PCR program consisted of
15 min at 95°C, followed by 45 cycles of 15 s at 95°C
and 30 s at 56°C in an Applied Biosystems AB7500
real-time instrument and associated software. Each
run included a positive control, a negative control
and a negative-process control (a blank sample ex-
tracted along with the gill samples). An internal pro-
cess control (IPC; Life technologies) and external pro-
cess control (salmonid elongation factor-1α; Bruno et
al. 2007) were used for every 20 samples tested.
Validation of reaction efficiency, sensitivity
and specificity
Once confirmed as N. perurans, the PCR product
produced was then cloned into the pGEM® Easy
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Vector systems (Promega) and purified using Gen -
Elute Plasmid Miniprep Kit (Sigma) according to the
manufacturer’s instructions. The plasmid concentra-
tion was measured spectrophotometrically at 260 nm,
and the value obtained was used to determine plas-
mid copy numbers, calculated using a DNA copy
number calculator (http://cels.uri.edu/gsc/ cndna. html).
To de termine the efficiency of the assay, Atlantic
salmon gills from freshwater were spiked with N.
perurans plasmid DNA and taken through the
extraction process as described above. A 10-fold
serial dilution was carried out in quadruplicate, and
each of the log dilutions were subjected to real-time
amplification as previously described. Only dilutions
that provided Ct values in all replicates were used
to generate a standard curve, which was created by
plotting the Ct values against the 10-fold dilutions of
N. perurans. Amplification efficiency of the real-
time PCR assay was established based on the Ct
slope method (Efficiency (Ex) = [10(−1/slope)] − 1), and
the linearity was determined as the coefficient of
correlation (R2). The dilution series was also used to
determine the sensitivity of the assay. The lowest
dilution which provided Ct readings in all replicates
was investigated further via a 2-fold dilution series
tested in quadruplicate, in order to determine the
limit of detection. This final dilution was then ana-
lysed a further 20 times to assess the precision of
the assay at a 95% confidence level. The specificity
of the assay primers and probe were initially deter-
mined theoretically using the Basic Local Alignment
Search Tool (BLAST) (http://blast.ncbi.nlm.nih.gov/
Blast.cgi) to identify po ten tial cross reactivity with
other species including Atlantic salmon. In addition,
DNA samples extracted from N. pemaquidensis, N.
branchiphilia and N. aestu a rina were also tested
using the real-time PCR assay.
Reproducibility
The reproducibility of the assay was evaluated by
investigating 7 different gill samples in triplicate.
These samples had previously tested positive by both
the Fringuelli et al. (2012) assay and the assay
described in this manuscript. All samples were tested
on 3 consecutive days, and results were analysed in
order to determine the coefficient of variation for
intra-assay variance and also inter-assay variance,
i.e. the variance in each of the sample triplicates
when compared between different PCR runs. The
reproducibility was analysed by relative standard
deviation.
Longitudinal study site and sampling details
The longitudinal study was carried out on a marine
Atlantic salmon fish farm on the south west coast of
Ireland. The site is fully oceanic with little or no varia-
tion in salinity levels throughout the year. It is situated
in an area that receives relatively high exposure, ex-
periencing a mean wave height of 1.97 m and a maxi-
mum wave height of 8.28 m. The approximate depth
of the bay where the site is situated is 23 m. In total,
800 000 salmon smolts with an average weight of 60 g
were transferred to the sea site during late April and
early May 2013. Sampling commenced 4 wk post
transfer on 3 May 2013, when the average weight of
the fish was 85 g, and continued until 19 September
2014, when the average weight of the fish was 4.6 kg.
At each sampling point, 5 feeding fish were selected
from 2 fixed cages on site (n = 10) using a hand net.
Moribund fish were avoided to ensure that fish sam-
pled were representative of the population as a
whole. At each sampling point, gill scoring (0 to 5) was
conducted on site using the method adapted from
Taylor et al. (2009) for AGD assessment. The second
gill arch on the left-hand side was excised from each
fish and immediately fixed in 10% neutral buffered
formalin for histological processing. Sections (5 µm)
from paraffin-embedded gill samples were stained with
haematoxylin and eosin and examined on an Olympus
BX51 microscope. Based on the typical histopathology
associated with AGD (fusion of the lamellae, hyper-
plasia and vesicle formation) and the presence of
amoebae (Adams & Nowak 2001, Mitchell et al. 2012),
a histopathology scoring scale was established for this
study. The scoring system was based on Mitchell et al.
(2012) and was applied to illustrate the progression
and severity of the gill lesions in fish where AGD de-
veloped: a score of 0 = normal gill, 1 = low pathology
(<10% of gill filament affected), 2 = moderate patho -
logy (<50% of gill filament affected), and 3 = severe
pathology (>50% of gill filament affected).
The second gill arch on the right-hand side was
excised from each fish and immediately placed in
1 ml RNA Later (Sigma) for molecular analysis. Total
DNA was extracted from 25 mg of gill filament using
the DNA Mini kit (Qiagen) and screened for N. peru-
rans by real-time PCR as described above.
In situ hybridisation
Sections were hybridised with a digoxigenin (DIG)-
labelled oligonucleotide probe specific to N. perurans
as previously described (Young et al. 2008). Gill fila-
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ment sections (7 µm) were placed on poly-L-lysine
coated glass slides (Sigma), and each section was de-
paraffinised in a series of xyleen/ethanol washes. The
proteinase K step was omitted. Sections were allowed
to dry, and a frame-seal (Biozym) was placed on the
slides to make a chamber before overlaying with a
mixture of 1 µl of PCR product (cultured amoebae
DNA amplified using primers by Young et al. [2008])
in 99 µl hybridisation buffer (5 ml formamide [Sigma],
1 g dextran sulphate [Sigma], 2 ml SSC buffer 20
[Roche], 2.5 mg tRNA [Roche], 200 µl Denhart’s solu-
tion 50  [Sigma] and 2.8 ml dH2O to a total volume of
10 ml). A cover slip was added, and the DNA was de-
natured at 94°C for 5 min in a slide block (Bio-Rad
Thermal cycler), then cooled directly on ice prior to
overnight incubation at 42°C. The coverslips were re-
moved, and the slides were sequentially washed in 
2 SSC buffer for 10 min (2×), 0.4× SSC buffer at 42°C
for 10 min followed by 5 min in DIG1 buffer (0.10 M
maleic acid, 0.15 M NaCl). Each slide was then over-
layed with 400 µl of DIG2 buffer (1% blocking
reagent [Roche] in DIG 1) and incubated in a humid
box at room temperature for 30 min. Each section was
given a short wash in DIG1 buffer prior to an overlay
of 400 µl of DIG 2 buffer plus 1:500 anti-DIG-alkaline
phosphate (Roche) and incubated for 1 h in a humid
box at room temperature. Slides were washed for
10 min in DIG1 (2×) and DIG3 (0.1 M Tris, 0.1 M NaCl,
and 0.05 M MgCl2H2O) for 5 min. Each section was
overlayed with 200 µl of NBT/BCIP (Roche) in DIG 3
and incubated for 25 min. The colour reaction was
stopped by 5 min incubation in DIG4 (10 mM Tris,
1 mM EDTA) buffer followed by counter-staining for
1 min with 0.5% Bismark Brown Y (Sigma) solution.
Slides were then dehydrated in ethanol and xylene,
before a coverslip was added.
Temperature and farm data
Temperature data were obtained us-
ing StowAway® Tidbit™ sensors which
were attached to 1 cage pontoon at the
site. Sensors were placed at depth of
10 m and logged temperature on an
hourly basis as part of the Marine In -
stitute Temperature Monitoring Pro-
gramme (www.marine.ie/home/publica -
tionsdata/data/ IMOS/IMOSTidbit. htm).
Gill scores, mortalities and the number
of freshwater bath treatments adminis-
tered for AGD were recorded by the
site manager. Mortality data was docu-
mented as the total weekly mortality per cage. Fresh-
water baths (2 to 3 h) were carried out at a number of
time points during this study. These treatments were
triggered based on the results of weekly gill checks,
when farms observed 30 to 40% of fish with a score of
2 or above (Rodger 2014).
RESULTS
DNA extraction and conventional PCR of 
cultured amoebae
Neoparamoeba perurans was successfully isolated
and cultured at 18°C on MYA plates, with washing
occurring every 3 d and amoebae seeded onto fresh
plates every 2 wk. Cultured isolates (Fig. 1A) were
tested via conventional PCR using N. perurans spe-
cific primers (Young et al. 2008) to confirm their iden-
tity. Amoebae were also observed in fresh gill mucus
scrapes from infected fish (Fig. 1B). Sequenced PCR
products were analysed via BLAST and showed 99%
similarity with sequences from Norway (KF146713),
Australia (GU574794) and Chile (GQ407108). The
18S rDNA sequences retrieved from the ethanol
fixed samples confirmed the identity of each amoeba
species, following BLAST analysis.
Real time primer and probe design
Following assay pre-optimisation experiments,
primer/ probe final concentrations of 300 nM NP1,
900 nM NP2 primer and 200 nM NPP probe were
used in all tests.
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Fig. 1. (A) Neoparamoeba perurans visualised growing on MYA plates in
 culture. (B) A fresh gill mucus scrape with amoeba migrating from the gills. 
Scale bar = 50 µm
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Validation of reaction efficiency, sensitivity
and specificity
The standard curve generated following testing of
a 7-log dilution series of the amoeba plasmid spiked
in Atlantic salmon gill had a slope of −3.363 and an
amplification efficiency of 98.44% with a linear cor-
relation coefficient of R2 = 0.999 (Fig. 2). The final
dilution that produced a cycle threshold (Ct) value in
all quadruplicates was 10−7 (Fig. 2). Analysis of serial
dilutions (1:2, 1:3, 1:4, 1:5, 1:6, etc.) of the 10−7 dilu-
tion showed that consistent results were found in all
replicates up to the 1:5 dilution, giving the assay a
reproducible cut-off Ct value of 40.13 (Table 1)
equivalent to 2.68 DNA copies per µl−1. This dilution
was tested a further 20 times in duplicate to assure
a 95% confidence (Table 2). Individual BLAST
searches conducted on both the primers and probe
sequences showed no similarity to any other amoeba
species. When tested experimentally with DNA iso-
lated from N. pemaquidensis, N. branchiphila and
N. aestuarina, no amplification was observed.
Reproducibility
The mean intra-assay variances ranged from 0.05
to 0.62% in the triplicates of the 7 samples tested.
Based on the 3 separate repeats of the PCR assay, the
inter-assay variation ranged from 0.24 to 0.48%
(Table 3).
Longitudinal study: temperature,
mortality and treatment dates
Sea water temperatures, % weekly
mortality rates and treatment dates for
the entire production cycle are shown
in Fig. 3. Sea temperatures ranged
from 7.8°C in April 2013 to 19.2°C in
July 2013. Two freshwater bath treat-
ments were carried out on all cages in
August (Week 18) and September 2013
(Week 24), with a further 4 treatments
occurring on a number of pens on site
in December 2013 (twice, Weeks 34
and 37) and in January (Week 39) and
June (Week 61) 2014. Three periods of
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Fig. 2. Amplification of quadruplicate log dilutions of Neoparamoeba perurans
plasmid DNA in Atlantic salmon gill samples. At each point, the Ct value was 
plotted against the dilution. Ex: amplification efficiency
Ct1 Ct2 Ct3 Ct4 Mean SD
1:2 37.71 37.43 36.64 36 36.95 0.78
1:3 38.03 39.72 38.9 37.42 38.52 1.01
1:4 40.12 38.66 38.96 39.24 39.25 0.63
1:5 40.31 40.02 40.36 39.81 40.13 0.26
1:6 42.83 nd 40.28 41.59 41.57 1.28
Table 1. Determination of the working limit of detection for
the TaqMan assay. The working limit of detection is in bold. 
nd: not determined
Ct value 1 Ct value 2 Mean SD
1 37.48 38.81 38.15 0.94
2 38.96 38.07 38.52 0.63
3 39.57 40.44 40.01 0.62
4 39.54 39.24 39.39 0.21
5 39.32 38.51 38.92 0.57
6 38.67 39.44 39.06 0.54
7 39.5 39.22 39.36 0.20
8 38.75 39.33 39.04 0.41
9 40.47 40.94 40.71 0.33
10 39.53 38.47 39.00 0.75
11 39.49 40.26 39.88 0.54
12 39.25 39.21 39.23 0.03
13 39.51 40.14 39.83 0.45
14 39.57 39.7 39.64 0.09
15 39.82 39.39 39.61 0.30
16 40.39 39.45 39.92 0.66
17 40.58 39.94 40.26 0.45
18 39.85 39.01 39.43 0.59
19 38.99 39.36 39.18 0.26
20 40.15 39.55 39.85 0.42
0.60 0.45
Table 2. The final dilution of the standard curve (Fig. 1)
which produced Ct values in all replicates was further ana-
lysed and tested 20 times (in duplicate) to determine the 
precision of the assay at a 95% confidence level
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elevated mortality occurred during the production
cycle, resulting in peak weekly mortality rates of 2, 3
and 2.5% respectively. However, after Week 38 (Jan-
uary 2014), weekly mortality rates remained below
0.5%. The first increase in mortality, which was due
to AGD, occurred in Week 13, peaked at Week 17
and declined from Week 18 onwards following a
freshwater treatment. Mortalities due to AGD gradu-
ally increased again from Week 22 but did not peak
due to a treatment in Week 24. A sharp increase in
mortality occurred in Week 26 due to a bloom of
 zooplankton, more specifically Pelagia noctiluca. The
third period of high mortality, due to AGD, occurred
between Weeks 32 and 37 and resulted in a number
of freshwater treatments for specific pens on site only
(Fig. 3).
Longitudinal study: PCR results, gill scores,
 histological scores
Sampling was initiated in Week 4 (3 May 2013) and
completed in Week 76 (19 September 2014) before
harvesting began. The average gill score, average
histological score and % PCR-positive results for the
entire production cycle are shown in Table 4. The first
PCR-positive samples were detected in Week 4; how-
ever, all fish sampled in Weeks 6, 8 and 9 were nega-
tive (Table 4, Fig. 4A). The numbers of  PCR-positive
fish started to increase from Week 12 until Week 16,
when all fish were positive and coincided with the
first peak of mortality. Following the freshwater treat-
ment in Week 18, only 10% of fish were PCR-positive
in Week 19, increasing to 80% by Week 24 due to the
second AGD outbreak. Following the second full site
treatment, 30% of fish were positive in Week 28 be-
fore increasing again to 100% by Week 32, prior to
the third AGD outbreak on site. During the second
half of the production cycle, PCR-positive fish were
detected up to the pre-harvest period in Week 76. The
first increase in mean gill score was observed in Week
16 (31 July 2013), coinciding with the first outbreak of
AGD with average gill score of 2.5 (Fig. 4B).
Following treatment, the mean gill score declined to
<0.5 by Week 21 before increasing again (to 1.5) in
Week 24 after the second AGD outbreak. During the
third AGD outbreak and for the remainder of the pro-
duction cycle, moderate mean gill scores were ob-
served but were never greater than 2. The average
histological gill score first increased (to 2.5) in Week
16 (Fig. 4C) and gradually reduced following treat-
ment showing a similar pattern to the mean gill
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Sample PCR assay 1 PCR assay 2 PCR assay 3 Inter-assay variance
Ct value Mean RSD% Ct value Mean RSD% Ct value Mean RSD% Mean RSD%
1 33.5 33.50 ± 0.05 0.13 33.43 33.40 ± 0.07 0.2 33.49 33.55 ± 0.07 0.19 33.48 ± 0.09 0.26
33.54 33.32 33.62
33.45 33.44 33.55
2 32.55 32.60 ± 0.1 0.31 32.42 32.51 ± 0.08 0.23 32.45 32.44 ± 0.05 0.16 32.52 ± 0.10 0.31
32.54 32.56 32.38
32.72 32.54 32.48
3 32.57 32.63 ± 0.07 0.2 32.42 32.52 ± 0.10 0.29 32.63 32.62 ± 0.02 0.07 32.59 ± 0.08 0.24
32.61 32.53 32.63
32.7 32.61 32.59
4 31.91 31.93 ± 0.02 0.05 31.55 31.76 ± 0.20 0.62 31.68 31.76 ± 0.08 0.24 31.82 ± 0.13 0.42
31.93 31.94 31.83
31.94 31.8 31.78
5 37.25 37.26 ± 0.19 0.51 36.95 37.14 ± 0.17 0.46 37 36.98 ± 0.03 0.08 37.13 ± 0.18 0.48
37.46 37.19 37
37.08 37.28 36.95
6 34.32 34.46 ± 0.21 0.6 34.36 34.46 ± 0.08 0.24 34.43 34.56 ± 0.11 0.32 34.49 ± 0.13 0.39
34.7 34.51 34.6
34.37 34.5 34.64
7 33.41 33.59 ± 0.16 0.47 33.5 33.61 ± 0.11 0.32 33.39 33.43 ± 0.09 0.26 33.55 ± 0.14 0.41
33.68 33.71 33.53
33.69 33.63 33.37
Table 3. Real-time PCR Ct values from the reproducibility testing using 7 samples of cultured Neoparamoeba perurans tested in triplicate. 
The mean (±SD) intra-assay variances ranged from 0.05 to 0.62%, while the inter-assay variance ranged from 0.24 to 0.48%
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scores. Amoebae were first observed
histologically in Week 16 (Table 4). The
presence of N. perurans was confirmed
by in situ hybridisation (Fig. 5A). Two
further increases in gross pathology
were observed in 2013 before a decline
to minimal levels in January and Feb-
ruary (Weeks 36 to 44). Histopathology
scores were re corded over the full range
of the scoring method (Fig. 5B−D), and
at each sampling point, some mild form
of pathology was consistently observed.
Amoebae were observed only on 3 oc-
casions: in Weeks 16 and 32 during the
first and third AGD outbreaks and
again in Week 45 (Table 4).
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Fig. 3. Seawater temperatures, % weekly mortality rates of Atlantic salmon
and the dates of freshwater bath treatments throughout the marine production 
cycle during the longitudinal study
Date Week Avg. gill Avg. histo- Histological results PCR results 
score logical score (% positive)
03/05/2013 4 0.1 0.5 No amoeba, no gill pathology (or No evidence of AGD) 30
17/05/2013 6 0 0.2 No amoeba, no gill pathology 0
31/05/2013 8 0 0.3 No amoeba, no gill pathology 0
07/06/2013 9 0.2 0.6 No amoeba, no gill pathology 0
28/06/2013 12 0 0.1 No amoeba, no gill pathology 10
05/07/2013 13 0 0.6 No amoeba, no gill pathology 40
26/07/2013 16 2.5 2.6 Severe pathology consistent with AGD observed in all of the gills. 100
Some amoeba observed
16/08/2013 19 2 1.9 No amoeba observed. Moderate gill pathology observed 10
30/08/2013 21 0.35 0.9 No amoeba observed. Low gill pathology observed 60
20/09/2013 24 1.5 1.2 No amoeba observed. Moderate gill pathology observed. Changes 80
associated with AGD
18/10/2013 28 0 0.8 No amoeba observed. Low to moderate gill pathology observed; 30
significant telangiectasis
01/11/2013 30 0.7 0.7 No amoeba observed. Low gill pathology observed 90
15/11/2013 32 1.1 1.4 Low to severe levels of gill pathology, some amoeba observed 100
29/11/2013 34 0.6 1.4 Amoeba observed, low to moderate gill pathology observed 90
13/12/2013 36 0.6 N/A 80
17/01/2014 41 0.5 0.1 No amoeba observed. Low level gill pathology observed 60
07/02/2014 44 0 0.8 Low gill pathology observed 10
14/07/2014 45 1.2 1.87 Low to severe levels gill pathology. Amoeba observed. 20
14/03/2014 49 1.7 2.1 Low to severe levels gill pathology. Some old scarring evident 30
21/03/2014 50 0.65 1.1 Low to moderate gill pathology observed some very focal hyperplasia 10
and fusion with old scarring
04/04/2014 52 1.4 2.2 Moderate to severe gill pathology observed 90
25/04/2014 55 0.85 1.95 Moderate to severe gill pathology, some telangiectasia evident 30
02/05/2014 56 0.6 1.4 Low to moderate gill pathology with some telangiectasia evident. 10
Some bleeding also noted
06/06/2014 61 1.5 1.3 Low to moderate gill pathology 100
13/06/2014 62 0.77 1.07 Mainly low level of pathology observed some with no significant 66
findings. Some severe level of pathology with telangiectasia evident
04/07/2014 65 2 1.9 Moderate to severe gill pathology observed 100
18/07/2014 67 0.3 1.6 Low to severe gill pathology observed, some telangiectasia evident 40
19/09/2014 76 0.7 2.4 Moderate to severe gill pathology observed with significant telangiectasia 70
Table 4. Average gill score, average histological score (with comments) and % PCR-positive Atlantic salmon throughout the marine 
production cycle during the longitudinal study. Dates given as dd/mm/yyyy. N/A: not applicable
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DISCUSSION
Over the last decade, gill pathologies have become
an increasing problem for the Atlantic salmon aqua-
culture industry in Northern Europe (Rodger et al.
2011). In recent years, jellyfish, zooplankton, phyto-
plankton, bacteria, viruses and parasites have all
been identified as causing fish kills and significant
gill pathology in farmed salmonids (Mitchell &
Rodger 2007, Doyle et al. 2008, Baxter et al. 2011),
although, in terms of economic impact, the most sig-
nificant gill disease currently affecting the industry is
AGD.
In 2011, AGD re-emerged as a significant disease
of marine farmed Atlantic salmon in Ireland and has
remained a major issue since then (Rodger
2014). The rapid detection of pathogens
is essential for the implementation of an
effective health management plan in aqua-
culture. This study aimed to develop a real-
time PCR assay for the detection of Neo -
para moeba perurans in Atlantic salmon gill
samples and to validate the assay as a sur-
veillance tool for AGD through the marine
grow-out phase of the production cycle.
The assay reported in this study was de -
signed to amplify a smaller (70 bp) segment
of the N. perurans 18S rRNA gene than the
one described by Frin guelli et al. (2012).
The assay optimised for the detection of N.
perurans had a high efficiency of 98.44%
and an R2 value of 0.999, within the ac -
cepted levels of 100 ± 10% (Purcell et al.
2011), and was able to repeatedly detect as
low as 2.68 copy numbers of N. perurans
DNA µl−1, which is at the theoretical limit of
sensitivity for real-time PCR assays (Bustin
et al. 2009).
Following optimisation, the assay was
then utilised in a longitudinal study for the
detection of N. perurans on a farm site in
the south west of Ireland. Longitudinal
studies have been used to investigate a
range of diseases of importance in aqua -
culture, such as heart and skeletal muscle
inflammation (Kongtorp et al. 2006), pan-
creas disease (Graham et al. 2010) and
AGD (Clark & Nowak 1999). These studies
provide important information on potential
risk factors, impact of the disease and on
the performance of diagnostic methods.
This study covered the full marine produc-
tion cycle from Week 4 post-transfer (3 May
2013) up until Week 76 (19 September 2014). During
this period, 3 peaks in mortality were recorded on the
site, each one due to an outbreak of AGD, although
the second mortality peak was also due to a large
bloom of Pelagia noctiluca, known to cause signifi -
cant pathology and mortality in farmed Atlantic
salmon (Marcos-López et al. 2014). Mortality started
to increase during Week 13, at a time when the sea-
water temperature first rose above 15°C. There was
an increase in the mean gill score and histological
score in Week 16, when pathology consistent with
AGD as well as amoebae were observed on the gills.
It is recognised that the histological gill score may
have been influenced by the buffered formalin fixa-
tive used in this study. The use of an alternative fixa-
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Fig. 4. Weekly mortality rates versus (A) % PCR-positive fish, (B) aver-
age gill scores, and (C) average histology scores, throughout the mar-
ine production cycle of Atlantic salmon during the longitudinal study
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tive such as Davidson’s may have resulted in higher
retention of amoebae on the gills sampled (Cadoret et
al. 2013); however, it was more practical to use
buffered formalin which is also routinely used in fish
histopathology. The sensitivity of the real-time assay
was demonstrated by the fact that positive fish were
already detected by Week 12 (10% of fish tested
were positive), and by Week 16, all fish tested were
positive for N. perurans.
Following the increase in mortality and diagnosis
of AGD, the site undertook a freshwater treatment of
every cage in Week 18 to treat for the disease. Sam-
ples collected 4 d post-treatment, during Week 19,
showed a reduction in the percentage of PCR-positive
fish (10%), which is in line with previous findings
where a reduction in the number of amoebae was
observed following freshwater bathing (Clark et al.
2003). Both the average gill and histological scores
were reduced by Week 21, as it can take up to 4 wk
post-treatment for gills to fully recover (Findlay et al.
2000). However, both gross and histological gill scor-
ing can be misleading due to the presence of scarring
from the previous infection, requiring adjustment in
their interpretation. Due to some amoebae remaining
and all cages not receiving treatments simultane-
ously, re-infection can occur as early as 1 wk post-
treatment and can increase in severity over the fol-
lowing weeks (Clark et al. 2003, Adams & Nowak
2004). This study confirmed a  similar re-infection
profile where an increase in the number of PCR-pos-
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Fig. 5. (A) In situ hybridisation using species-specific oligonucleotide probes on Atlantic salmon gill sections examined from
the study site. (Inset) Reactive dark cells indicate the presence of N. perurans. (B−D) Examples of the different levels of pathol-
ogy observed in the gills of Atlantic salmon during this study: (B) a score of ‘1’ was assigned to a section where <10% pathol-
ogy was observed; (C) a histological score of ‘2’ where there is between 10 and 50% pathology observed; (D) gills with >50%
pathology showing complete loss of structure due to hyperplasia and fusion and (inset) amoeba present (histological score of ‘3’)
Downes et al.: PCR screening of AGD in salmon
itive fish by Week 21, only 3 wk following the first
freshwater bath, was observed. Inter estingly, it was
6 wk post-treatment when an increase in the average
gill score and histology score was observed, and a
second full site treatment was required in Week 24.
In total, there were 6 recorded freshwater bath treat-
ment events over the course of the study, the first 2
involving treatment of each cage on site while the 4
subsequent treatments were ad ministered to a subset
of specifically selected cages.
The PCR assay developed in this study was shown
to have a beneficial role in monitoring the progress
of the disease, in particular with detection of the
amoeba 3 wk prior to detection via gross pathology.
The ability of this assay to detect amoebae a number
of weeks prior to traditional diagnostics can po -
tentially provide farm managers with valuable infor-
mation to effectively plan treatments. Such infor -
mation is important where infrastructure (wellboats)
and the resources required (access to freshwater) for
treatment are limited (Nowak 2012). As traditional
de tection methods require advanced stages of the
disease in a greater proportion of the population, use
of molecular-based diagnostic tools could al low for
earlier intervention strategies. Although the tradi-
tional screening methods (gill scores, wet-preparations
and histology) are important tools for on-site monitor-
ing of AGD, significant experience is required as
amoebae can be difficult to differ entiate from gill
epithelial cells and observation of amoebae cells
is not always possible, particularly when infection
 levels are low (Munday et al. 2001).
Interestingly, the levels of weekly mortalities
recorded during the outbreaks of AGD on the sur-
veillance site were slightly lower than that observed
in outbreaks of AGD in Tasmania where levels of 2 to
4% per week were recorded in fish weighing 1 to
2 kg (Munday et al. 2001). In this study, the weekly
mortality peaked at just over 2% in the first year of
production when fish weighed <1 kg. Following a
reduction in temperature in January and February
2014 and fish weights increasing >1 kg, the percent-
age mortality returned to background levels for the
remainder of the study.
This is the first study of AGD conducted under field
conditions over a full marine production cycle on a
farm in Ireland. During this study, there were 3 sepa-
rate outbreaks of AGD on this site. Each outbreak
was preceded by a rise in the number of fish testing
positive by PCR and subsequently by increased gill
and histology scores. The development of an early
detection method that is economical, sensitive and
specific to diagnose AGD in the early stages of
 infection is an extremely valuable tool. As with other
diagnostic methods, further  considerations are re -
quired, and all on-site factors and observations must
be taken into account when preparing a diagnosis
(Munday et al. 2001). This was evidenced in the sec-
ond year of production when PCR-positive fish, gill
scores and histo logy scores indicative of infection
with N. perurans were recorded, although mortality
levels remained low. While the immune response of
Atlantic salmon to N. perurans is still poorly under-
stood, there is some evidence to suggest that the
fish that have survived an initial challenge of AGD
develop some resistance or tolerance to the parasite
(Vincent et al. 2006, Taylor et al. 2009, Valdenegro-
Vega et al. 2015). This may also be influenced by dif-
fering genetic traits for the mechanisms involved in
the resistance to the first and subsequent infections
(Kube et al. 2012).
In conclusion, the assay developed in this study
demonstrated potential as a tool to complement exist-
ing techniques for monitoring AGD. Future studies,
utilising non-lethal gill swabs, will further enhance
monitoring capabilities for AGD by the aquaculture
industry.
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